Management of the acute porphyrias

Photodermatology Photoimmunology and Photomedicine

Volumn 14, Issue 2, 1998, Pages 48-51

  Kauppinen, R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Porphyria; Treatment

Indexed keywords

HEMATIN; HEME; HEME ARGINATE; PORPHOBILINOGEN; PORPHYRIN;

ACUTE INTERMITTENT PORPHYRIA; ALCOHOL CONSUMPTION; CALORIC INTAKE; CLINICAL FEATURE; DIET RESTRICTION; DRUG USE; GASTROINTESTINAL SYMPTOM; HEPATIC PORPHYRIA; HUMAN; HYPERTENSION; INFECTION; MOTOR NEUROPATHY; PARENTERAL NUTRITION; PERIPHERAL NEUROPATHY; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; THROMBOPHLEBITIS;

EID: 0031838931     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1998.tb00010.x     Document Type: Review

References (21)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias: In: Scriver CR, Beaudet A, Sly WS, Valle DJ, eds. The metabolic and molecular basis of inherited diseases. New York: McGraw-Hill, 1995: 2116-2160.
2. Kauppinen R, Mustajoki P. Prognosis of acute hepatic porphyria: occurrence of acute attacks, precipitating factors and associated diseases. Medicine 1992: 71: 1-13.
3. Moore MR, McColl KEL, Rimington C, Goldberg A. Disorders of porphyrin metabolism. 1st edn. New York: Plenum Medical Book Company, 1987.
4. Mustajoki P, Koskelo P. Hereditary hepatic porphyrias in Finland. Acta Med Scand 1976: 200: 171-178.
5. Lamon JM, Frykholm BC, Bennett M, Tscudy DP. Prevention of acute porphyric attacks by intravenous hematin. Lancet 1978: ii: 492-494.
6. Doss M, von Tiebermann R, Schneider J, Schmid H. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr 1979: 57. 1123-1127
7. Mauzerall D, Granick S. The occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956: 219: 435-446.
8. Anderson KE. The porphyrias. In: Plum F, Bennet JC, eds. Cecil textbook of medicine, 20th edn. Philadelphia: W.B. Saunders Company, 1996: 1124-1130
9. Mustajoki P, Tenhunen R, Pierach C, VoLin L. Heme in the treatment of porphyrias and hematological disorders Semin Hematol 1989: 26: 1-9.
10. Tenhunen R, Tokola O, Linden I-B. Haem arginate: a new stable haem compound. J Pharm Pharmacol 1987: 39: 780-786.
11. Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attack. Arch Intern Med 1993: 53: 2004-2008.
12. Anderson KE. LHRH analogues for hormonal manipulation in acute intermittent porphyria. Semin Hematol 1989: 26: 10-15.
13. Perlroth MG, Marver HS, Tschudy DP. Oral contraceptive agents and the management of acute intermittent porphyria. JAMA 1965: 194: 1037-1042.
14. Timonen K, Niemi KM, Mustajoki P, Tenhunen R. Skin changes in variegate porphyria. Clinical, histopathological and ultrastructural study. Arch Dermatol Res 1990: 282: 108-114.
15. Brodie MJ, Thompson CG, Moore MR, Beattie AD, Goldberg A. Hereditary coproporphyria. QJM 1977: 46: 229-241.
16. Mustajoki P. Variegate porphyria. Twelve years' experience in Finland. QJM 1980: 49: 191-203.
17. Andersson C. Acute intermittent porphyria in northern Sweden. A population based study. Umeå University Medical Dissertations, 1997: 497.
18. Bengtsson NO, Hardell L. Porphyrias, porphyrins and hepatocellular cancer. Br J Cancer 1986: 54: 115-117.
19. Kauppinen R, Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma Br J Cancer 1987: 57: 117-120.
20. Andersson C, Bjersing L, Lithner F. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Int Med 1996: 240: 195-201.
21. Andersson C, Lithner F. Hypertension and renal disease in patients with acute intermittent porphyria. J Int Med 1994: 236: 169-175.